Summarized by Masters of Longevity from Longevity Docs News.
CMS will invite manufacturers to apply to its expanded outcomes‑based CGT Access Model.
Key Takeaways
- CMS is expanding the CGT Access Model beyond sickle cell disease.
- The model ties part of therapy payment to whether agreed outcomes are met.
- The first evaluation found negotiations eased administrative burden for states.
